Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Schiewer

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Cold Spring Harbor Perspectives in Medicine|March 14, 2018
DNA Damage Response in Prostate CancerMatthew J Schiewer, Karen E Knudsen
Cancer Cell|April 12, 2017
Not So Fast: Cultivating miRs as Kinks in the Chain of the Cell CycleMatthew J Schiewer, Karen E Knudsen
Molecular Cancer Research : MCR|June 12, 2014
Transcriptional roles of PARP1 in cancerMatthew J Schiewer, Karen E Knudsen
The Urologic Clinics of North America|July 2, 2021
Basic Science and Molecular Genetics of Prostate Cancer AggressivenessMatthew J Schiewer, Karen E Knudsen
Trends in Endocrinology and Metabolism: TEM|March 6, 2016
Linking DNA Damage and Hormone Signaling Pathways in CancerMatthew J Schiewer, Karen E Knudsen
EMBO Molecular Medicine|February 25, 2014
AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapyMatthew J Schiewer, Karen E Knudsen
Cancer Research|April 18, 2024
PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate CancerMoriah L Cunningham, Matthew J Schiewer
Molecular and Cellular Endocrinology|July 26, 2011
The AR dependent cell cycle: mechanisms and cancer relevanceMatthew J Schiewer, Michael A Augello, Karen E Knudsen
Current Treatment Options in Oncology|May 26, 2017
PARP Inhibitors in Prostate CancerPraveen Ramakrishnan Geethakumari, Matthew J Schiewer, Karen E Knudsen, et al.
Molecular Cancer Research : MCR|August 15, 2015
Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer ProgressionRandy S Schrecengost, Staci N Keller, Matthew J Schiewer, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cold Spring Harbor Perspectives in Medicine|March 14, 2018
DNA Damage Response in Prostate CancerMatthew J Schiewer, Karen E Knudsen
Cancer Cell|April 12, 2017
Not So Fast: Cultivating miRs as Kinks in the Chain of the Cell CycleMatthew J Schiewer, Karen E Knudsen
Molecular Cancer Research : MCR|June 12, 2014
Transcriptional roles of PARP1 in cancerMatthew J Schiewer, Karen E Knudsen
The Urologic Clinics of North America|July 2, 2021
Basic Science and Molecular Genetics of Prostate Cancer AggressivenessMatthew J Schiewer, Karen E Knudsen
Trends in Endocrinology and Metabolism: TEM|March 6, 2016
Linking DNA Damage and Hormone Signaling Pathways in CancerMatthew J Schiewer, Karen E Knudsen
EMBO Molecular Medicine|February 25, 2014
AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapyMatthew J Schiewer, Karen E Knudsen
Cancer Research|April 18, 2024
PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate CancerMoriah L Cunningham, Matthew J Schiewer
Molecular and Cellular Endocrinology|July 26, 2011
The AR dependent cell cycle: mechanisms and cancer relevanceMatthew J Schiewer, Michael A Augello, Karen E Knudsen
Current Treatment Options in Oncology|May 26, 2017
PARP Inhibitors in Prostate CancerPraveen Ramakrishnan Geethakumari, Matthew J Schiewer, Karen E Knudsen, et al.
Molecular Cancer Research : MCR|August 15, 2015
Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer ProgressionRandy S Schrecengost, Staci N Keller, Matthew J Schiewer, et al.
Pageof 5